Logo

Sanofi-Aventis Deploys Ingenuity Software Globally

Mar 07, 2006

NEW YORK, March 7 (GenomeWeb News) - Sanofi-Aventis has licensed Ingenuity Content and Ingenuity Pathways Analysis software for global deployment, Ingenuity said today.

 

The deal is an expansion of a licensing agreement between the companies dating to 2003.

 

Financial details were not provided.

Breaking News
The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.